[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT07212166":3,"trial-entities:NCT07212166":148,"trial-summary:NCT07212166":152},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":7,"overall_status":8,"completion_date":9,"status_verified_date":10,"last_update_date":11,"start_date":12,"sponsor_name":13,"lead_sponsor_class":14,"has_dmc":15,"brief_summary":16,"detailed_description":15,"conditions":17,"keywords":19,"study_type":22,"primary_purpose":15,"phases":23,"enrollment_info":24,"interventions":27,"primary_outcomes":38,"secondary_outcomes":47,"sex":48,"minimum_age":49,"maximum_age":50,"healthy_volunteers":51,"eligibility_criteria":52,"std_ages":64,"locations":67,"central_contacts":135,"overall_officials":141,"references":144,"see_also_links":145},"NCT07212166","25-213","A Study of Questionnaires in Adolescents and Young Adults With Cancer","Psychometric and Linguistic Validation of PRO-AYA: Patient-Reported Outcomes for Adolescents and Young Adults (15-39) With Cancer","RECRUITING","2027-09-30","2026-08","2026-08-04","2025-09-30","Memorial Sloan Kettering Cancer Center","OTHER",null,"The purpose of this study is to evaluate a questionnaire called PRO-AYA: Patient-Reported Outcomes for Adolescents and Young Adults.",[18],"Adolescents and Young Adults With Cancer",[20,21],"PRO-AYA: Patient-Reported Outcomes for Adolescents and Young Adults","Psychometric and Linguistic Validation","OBSERVATIONAL",[],{"count":25,"type":26},120,"ESTIMATED",[28,33],{"type":14,"name":29,"description":30,"armGroupLabels":31},"Patient-Reported Outcome Surveys","PRO-AYA , Patient-Reported ECOG PS, EORTC QLQ-C30, Demographic\u002FClinical Characteristics",[32],"AYAs with cancer who are at least three months post treatment with no additional treatment planned",{"type":14,"name":34,"description":35,"armGroupLabels":36},"Spanish version of PRO-AYA and the cognitive interview","Revised Spanish PRO-AYA, Demographic\u002FClinical Characteristics",[37],"AYAs(Adolescents and Young Adults) who are fluent or prefer their healthcare be delivered in Spanish",[39,43],{"measure":40,"description":41,"timeFrame":42},"Test-retest reliability","The test-retest reliability will be based on the intraclass correlation (ICC) coefficients between the baseline and follow-up domain scores of PRO-AYA.","up to one month",{"measure":44,"description":45,"timeFrame":46},"Linguistically validate PRO-AYA or patients who prefer their healthcare be delivered in Spanish. (Cohort 2)","The primary goal of these cognitive interviews is to ensure that the wording and\u002For phrasing of the instructions, questions and answer choices are appropriate for native Spanish-speakers. The wording and phrasing are a result of direct translation of the English version of the PRO-AYA to a Spanish version.","up to a month",[],"ALL","15 Years","39 Years",false,{"inclusion":53,"exclusion":62,"raw_text":63},[54,55,56,57,58,59,60,61],"English- or Spanish proficient","Between the ages of 15-39","Diagnosed with cancer or the recurrence of a cancer as per clinician report and\u002For received active treatment for cancer between the ages of 15-39","Able to complete questionnaires by themselves or with assistance as per self-report","For Cohort 1 ONLY:","3 months from last treatment without plan to initiate any form of cancer-directed treatment in the next 3 months OR","On chronic cancer-directed therapy for the last 3 months without plan to change cancer-directed therapy in the next 3 months AND","ECOG Performance Status (0-4) or KPS\u002FLansky Score (0-100)",[],"Inclusion Criteria:\n\n* English- or Spanish proficient\n\n  o As assessed by two items: How well do you speak English? What is your preferred language for healthcare?\n* Between the ages of 15-39\n* Diagnosed with cancer or the recurrence of a cancer as per clinician report and\u002For received active treatment for cancer between the ages of 15-39\n* Able to complete questionnaires by themselves or with assistance as per self-report\n* For Cohort 1 ONLY:\n\n  * 3 months from last treatment without plan to initiate any form of cancer-directed treatment in the next 3 months OR\n  * On chronic cancer-directed therapy for the last 3 months without plan to change cancer-directed therapy in the next 3 months AND\n  * ECOG Performance Status (0-4) or KPS\u002FLansky Score (0-100)",[65,66],"CHILD","ADULT",[68,82,91,100,110,119,126],{"facility":69,"status":8,"city":70,"state":71,"zip":72,"country":73,"contacts":74,"geoPoint":79},"Memorial Sloan Kettering Basking Ridge (Consent Only)","Basking Ridge","New Jersey","07920","United States",[75],{"name":76,"role":77,"phone":78},"Thomas Atkinson, PhD","CONTACT","646-888-0089",{"lat":80,"lon":81},40.70621,-74.54932,{"facility":83,"status":8,"city":84,"state":71,"zip":85,"country":73,"contacts":86,"geoPoint":88},"Memorial Sloan Kettering Monmouth (Consent Only)","Middletown","07748",[87],{"name":76,"role":77,"phone":78},{"lat":89,"lon":90},40.39428,-74.11709,{"facility":92,"status":8,"city":93,"state":71,"zip":94,"country":73,"contacts":95,"geoPoint":97},"Memorial Sloan Kettering Bergen (Consent Only)","Montvale","07645",[96],{"name":76,"role":77,"phone":78},{"lat":98,"lon":99},41.04676,-74.02292,{"facility":101,"status":8,"city":102,"state":103,"zip":104,"country":73,"contacts":105,"geoPoint":107},"Memorial Sloan Kettering Commack (Consent Only)","Commack","New York","11725",[106],{"name":76,"role":77,"phone":78},{"lat":108,"lon":109},40.84288,-73.29289,{"facility":111,"status":8,"city":112,"state":103,"zip":113,"country":73,"contacts":114,"geoPoint":116},"Memorial Sloan Kettering Westchester (Consent Only)","Harrison","10604",[115],{"name":76,"role":77,"phone":78},{"lat":117,"lon":118},40.96899,-73.71263,{"facility":13,"status":8,"city":103,"state":103,"zip":120,"country":73,"contacts":121,"geoPoint":123},"10065",[122],{"name":76,"role":77,"phone":78},{"lat":124,"lon":125},40.71427,-74.00597,{"facility":127,"status":8,"city":128,"state":103,"zip":129,"country":73,"contacts":130,"geoPoint":132},"Memorial Sloan Kettering Nassau (Consent Only)","Uniondale","11553",[131],{"name":76,"role":77,"phone":78},{"lat":133,"lon":134},40.70038,-73.59291,[136,138],{"name":76,"role":77,"phone":78,"email":137},"atkinsot@mskcc.org",{"name":139,"role":77,"phone":140},"Marie Barnett, PhD","646-608-8206",[142],{"name":76,"affiliation":13,"role":143},"PRINCIPAL_INVESTIGATOR",[],[146],{"label":13,"url":147},"http:\u002F\u002Fwww.mskcc.org\u002Fmskcc\u002Fhtml\u002F44.cfm",{"nct_id":4,"conditions":149,"biomarkers":151},[150],"Malignant Neoplasm",[],{"nct_id":4,"found":153,"summary":154,"prompt_version":164},true,{"design":155,"status":156,"heading":157,"summary":158,"follow_up":159,"word_count":160,"commitments":161,"compensation":162,"drugs_mentioned":163},"This is an observational study that plans to enroll 120 participants. It is not specified if it is randomized or blinded.","completed","Study of Questionnaires in Adolescents and Young Adults With Cancer","This study is looking at questionnaires for adolescents and young adults (ages 15-39) who have cancer. The main goal is to check how reliable a questionnaire called PRO-AYA (Patient-Reported Outcomes for Adolescents and Young Adults) is, and to make sure a Spanish version of it works well for Spanish-speaking patients. You can join if you are between 15 and 39, have been diagnosed with cancer, and can speak English or Spanish. The study is considered successful if the questionnaires are found to be reliable and the Spanish version is validated. The current recruitment status is unclear.","The primary endpoints are measured at up to one month.",96,"You would complete questionnaires, including PRO-AYA, Patient-Reported ECOG PS, and EORTC QLQ-C30. For some participants, this would also involve a cognitive interview for the Spanish PRO-AYA. These assessments would be measured at up to one month.","Not stated in the trial record.",[],"v2"]